Close
Novotech
Jabsco PureFlo 21 Single Use

Intelligence platform Suppleye launches to help pharmaceutical professionals navigate supply market news

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

Leave Message for Us to Get Back

Related stories

Gilead Advances ADC Pipeline Expansion with $3B Tubulis Deal

Gilead Sciences has agreed to acquire Germany-based Tubulis in...

Neurocrine Nears $2.5bn Soleno Therapeutics Acquisition

Neurocrine Biosciences is close to securing a more than...

Biogen to Acquire Apellis for $5.6 Billion in Major Deal

Biogen Inc. has agreed to acquire Apellis Pharmaceuticals Inc....
- Advertisement -

Business intelligence platform Suppleye has launched a free tool to help pharmaceutical professionals stay on top of critical supply market news.

Suppleye provides users with an intelligent resource to monitor key market news within the pharmaceutical sector and track sentiment. Users can select from an initial list of general category feeds and from over 3,000 of the most well-known suppliers to organizations across the UK, Europe and North America.

Simon Geale, Managing Director of Suppleye, said: “It is critical that pharma professionals understand the latest news about suppliers, their competitors and broader markets. But the fact is, following supplier markets is more than a full-time job.

“In a world where expertise and insight are valued, it’s disappointing that so many have to rely on general search, static data or broad feeds for their market information. Suppleye provides pharma professionals with a real time window to the outside world that enables them to be better informed, all of the time. The speed, quality and curation of Suppleye’s feeds ensure that pharma professionals can stay abreast of a rapidly changing sector. “

The launch of Suppleye comes after the pandemic has strained supply chains and challenged pharmaceutical companies throughout 2020. Suppleye users will enjoy curated insights to keep them informed of key market events.

Suppleye launches with a free offering that features news and sentiment analysis on over 3000 suppliers and categories. This will shortly to be followed by Suppleye Pro and Suppleye Teams which will offer a more bespoke experience for individuals and teams.

Latest stories

Related stories

Gilead Advances ADC Pipeline Expansion with $3B Tubulis Deal

Gilead Sciences has agreed to acquire Germany-based Tubulis in...

Neurocrine Nears $2.5bn Soleno Therapeutics Acquisition

Neurocrine Biosciences is close to securing a more than...

Biogen to Acquire Apellis for $5.6 Billion in Major Deal

Biogen Inc. has agreed to acquire Apellis Pharmaceuticals Inc....

Trump Announces 100% US Pharma Tariffs for Patented Drugs

The US pharma tariffs policy has been formalised through...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access theMedia Pack Now

– Book a Conference Call

Leave Message for Us to Get Back

Translate »